Axa’s iShares MSCI Poland ETF EPOL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-13,100
Closed -$271K 1203
2019
Q3
$271K Hold
13,100
﹤0.01% 1201
2019
Q2
$311K Hold
13,100
﹤0.01% 1155
2019
Q1
$300K Hold
13,100
﹤0.01% 1195
2018
Q4
$301K Hold
13,100
﹤0.01% 1173
2018
Q3
$312K Hold
13,100
﹤0.01% 1223
2018
Q2
$285K Hold
13,100
﹤0.01% 1240
2018
Q1
$329K Hold
13,100
﹤0.01% 1241
2017
Q4
$355K Hold
13,100
﹤0.01% 1206
2017
Q3
$347K Hold
13,100
﹤0.01% 1163
2017
Q2
$318K Buy
13,100
+1,100
+9% +$25.8K ﹤0.01% 1130
2017
Q1
$259K Hold
12,000
﹤0.01% 1184
2016
Q4
$217K Buy
+12,000
New +$214K ﹤0.01% 1199
2016
Q3
Sell
-7,700
Closed -$131K 1233
2016
Q2
$131K Hold
7,700
﹤0.01% 1217
2016
Q1
$156K Hold
7,700
﹤0.01% 1172
2015
Q4
$139K Hold
7,700
﹤0.01% 1210
2015
Q3
$160K Hold
7,700
﹤0.01% 1242
2015
Q2
$176K Hold
7,700
﹤0.01% 1234
2015
Q1
$180K Hold
7,700
﹤0.01% 1254
2014
Q4
$185K Hold
7,700
﹤0.01% 1271
2014
Q3
$219K Hold
7,700
﹤0.01% 1225
2014
Q2
$226K Hold
7,700
﹤0.01% 1213
2014
Q1
$231K Hold
7,700
﹤0.01% 1203
2013
Q4
$229K Hold
7,700
﹤0.01% 1200
2013
Q3
$221K Hold
7,700
﹤0.01% 1129
2013
Q2
$187K Buy
+7,700
New +$201K ﹤0.01% 1116

Other funds holding EPOL

Axa's EPOL Position: Q4 2019 in Review

Axa sold out of iShares MSCI Poland ETF (EPOL) in Q4 2019, closing a stake of 13,100 shares — an estimated $271K sold.

Axa first reported a position in EPOL in Q2 2013 and held it in 25 quarters. The position peaked at $355K in Q4 2017. 62 funds tracked by Wall St. Rank hold EPOL as of Q4 2019.

  • Axa reported no remaining iShares MSCI Poland ETF position as of Q4 2019 after selling out during the quarter.
  • Axa sold 13,100 iShares MSCI Poland ETF shares in Q4 2019, an estimated $271K.
  • Axa first reported a position in iShares MSCI Poland ETF in Q2 2013 and held it in 25 quarters.
  • Axa's iShares MSCI Poland ETF position peaked at $355K in Q4 2017.
  • 62 funds tracked by Wall St. Rank held iShares MSCI Poland ETF as of Q4 2019.

Based on Axa's 13F filing for Q4 2019, filed 18 Feb 2020.